发明名称 |
Intravenous solutions for a derivative of staurosporine |
摘要 |
The invention relates to a novel advantageous dosage form for sparingly soluble staurosporin derivatives, especially N-benzoyl-staurosporin. The dosage form is administrable intravenously in the form of a nanoemulsion and comprises as solubilisers a combination of phospholipids, triglycerides and partial fatty acid esters of polyoxyethylene sorbitan.
|
申请公布号 |
US5658898(A) |
申请公布日期 |
1997.08.19 |
申请号 |
US19950553126 |
申请日期 |
1995.11.07 |
申请人 |
CIBA GEIGY CORPORATION |
发明人 |
WEDER, HANS GEORG;ISELE, UTE |
分类号 |
A61K9/127;A61K9/107;A61K31/55;A61K31/553;A61K47/14;A61K47/24;A61P9/00;A61P9/10;A61P31/04;A61P35/00;C07D498/22;(IPC1-7):A61K31/55 |
主分类号 |
A61K9/127 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|